Overview
Human Chronic Lymphocytic Leukemia (Serum for Research
Our Chronic Lymphocytic Leukemia Serum is sourced from IRB-consented donors clinically diagnosed with Chronic Lymphocytic Leukemia (CLL). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for biomarker studies.
Product Features
- Collected from clinically confirmed CLL donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
Donor Metadata
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for CLL
- Metabolic and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Chronic Lymphocytic Leukemia serum is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.
Protocols and Documentation
Document Type | Technical Document |
---|---|
PDF > | Serum Isolation |
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.